Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results

Rhea-AI Summary

Aurora Spine (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices for spinal surgery, has announced a conference call to discuss its third quarter fiscal 2024 financial results for the period ended September 30, 2024. The conference call is scheduled for Monday, October 28, 2024, at 11:00 a.m. Eastern Time. Investors can join via phone or webcast, with replay options available until November 4, 2024.

CARLSBAD, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update investors and discuss its third quarter fiscal 2024 financial results that ended September 30, 2024. Management will host the conference call on Monday October 28, 2024 at 11:00 a.m. Eastern Time.

Third Quarter 2024 Conference Call Details

Date and Time: Monday, October 28, 2024, at 11:00 a.m. ET / 8:00 a.m. PT

Call-in Information: Interested parties can access the conference call by dialing (844) 861-5497 or (412) 317-5794.

Webcast: Interested parties can access the conference call via a live webcast, which is available via the following link: https://app.webinar.net/y2kqEAqEXWA.

Replay: A teleconference replay of the call will be available until November 4, 2024, at (877) 344-7529 or (412) 317-0088, replay access code 3686054. Additionally, a replay of the webcast will be available at https://app.webinar.net/y2kqEAqEXWA for 90 days.

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Contact:

Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com

FAQ

When will Aurora Spine (ASAPF) report Q3 2024 earnings?

Aurora Spine (ASAPF) will report its third quarter fiscal 2024 financial results on Monday, October 28, 2024, at 11:00 a.m. Eastern Time.

How can investors access Aurora Spine's (ASAPF) Q3 2024 earnings call?

Investors can access the conference call by dialing (844) 861-5497 or (412) 317-5794, or via webcast at https://app.webinar.net/y2kqEAqEXWA.

How long will Aurora Spine's (ASAPF) Q3 2024 earnings call replay be available?

The teleconference replay will be available until November 4, 2024, while the webcast replay will be accessible for 90 days.